Although CO is considered as an essential risk factor of MetS according to the definition of IDF, our data do not support to use CO solely in the prediction of dysregulation of MetS-related signalling (e.g., ghrelin signalling). The gene discussed is GHRL; the disease is metabolic syndrome.